Ventyx Biosciences, Inc. (VTYX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Total Current Assets | 201.09M | 219.32M | 242.56M | 229.63M | 289.41M | 256.93M | 319.76M | 264.35M | 308.09M | 346.7M | 387.05M | 330.69M | 418.39M | 252.19M | 257.5M | 263.02M | 145.66M | 105.03M | 0 | 245K |
| Cash & Short-Term Investments | 192.64M | 208.96M | 228.81M | 217.32M | 274.82M | 239.44M | 302.58M | 252.22M | 300.82M | 332.25M | 376.92M | 317.94M | 412.42M | 250.45M | 254.35M | 258.58M | 141.95M | 102.79M | 0 | 244K |
| Cash Only | 31.97M | 32.3M | 28.08M | 27.26M | 61.77M | 40.92M | 141.9M | 51.58M | 56.61M | 51.72M | 63.67M | 64.82M | 263.27M | 45.34M | 41.69M | 70.79M | 68.99M | 102.79M | 0 | 244K |
| Short-Term Investments | 160.67M | 176.66M | 200.73M | 190.06M | 213.06M | 198.51M | 160.68M | 200.64M | 244.21M | 280.54M | 313.25M | 253.12M | 149.15M | 205.11M | 212.66M | 187.78M | 72.97M | 0 | 0 | 0 |
| Accounts Receivable | 0 | 1M | 500K | 1M | 0 | 0 | 0 | 0 | 0 | 0 | 49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 8.46M | 9.36M | 13.25M | 11.3M | 400K | 17.49M | 17.18M | 12.13M | 7.27M | 14.45M | 10.09M | 12.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 10.37M | 10.69M | 10.92M | 46.94M | 11.69M | 52.26M | 12.32M | 13.35M | 13.61M | 2.06M | 2.12M | 40.71M | 2.06M | 9.99M | 20.45M | 28.46M | 3.05M | 888K | 0 | 0 |
| Property, Plant & Equipment | 9.38M | 9.7M | 9.94M | 10.28M | 10.62M | 10.92M | 11.24M | 12.27M | 12.53M | 1.96M | 2.02M | 1.94M | 1.98M | 2.02M | 1.59M | 254K | 219K | 72K | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 975K | 0 | 35.62M | 0 | 40.26M | 0 | 0 | 0 | 0 | 0 | 38.67M | 0 | 7.9M | 18.8M | 28.15M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 987K | 12K | 987K | 1.03M | 1.07M | 1.08M | 1.08M | 1.08M | 1.08M | 102K | 96K | 96K | 72K | 72K | 60K | 60K | 2.83M | 816K | 0 | 0 |
| Total Assets | 211.47M | 230.01M | 253.48M | 276.56M | 301.1M | 309.19M | 332.08M | 277.69M | 321.7M | 348.76M | 389.17M | 371.4M | 420.44M | 262.19M | 277.95M | 291.48M | 148.71M | 105.92M | 0 | 245K |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -29.77% | -25.61% | -23.67% | -0.41% | -6.4% | -11.35% | -14.67% | -25.23% | -23.49% | 33.02% | 40.01% | 27.42% | 182.73% | 147.54% | - | 118872.24% | - | - | - | - |
| Total Current Liabilities | 11.26M | 11.47M | 12.39M | 12.78M | 12.3M | 18.1M | 14.53M | 22.27M | 26.21M | 20.03M | 16.52M | 16.36M | 35.66M | 17.67M | 17.79M | 12.28M | 11.81M | 8.06M | 0 | 1.4M |
| Accounts Payable | 993K | 913K | 2.32M | 3.13M | 2.29M | 6.58M | 5.58M | 5.76M | 9.34M | 4.08M | 6.55M | 6.43M | 18.58M | 5.8M | 7.11M | 4.66M | 4.26M | 2.37M | 0 | 1.1M |
| Days Payables Outstanding | - | - | - | - | - | 7.6K | 4.99K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 6.01M | 0 | 3.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 17.86x | 19.12x | 19.57x | 17.97x | 23.52x | 14.19x | 22.00x | 11.87x | 11.76x | 17.31x | 23.44x | 20.21x | 11.73x | 14.27x | 14.47x | 21.41x | 12.33x | 13.02x | - | 0.17x |
| Quick Ratio | 17.86x | 19.12x | 19.57x | 17.97x | 23.52x | 14.19x | 22.00x | 11.87x | 11.76x | 17.31x | 23.44x | 20.21x | 11.73x | 14.27x | 14.47x | 21.41x | 12.33x | 13.02x | - | 0.17x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 8.84M | 9.16M | 9.45M | 9.74M | 10.03M | 10.29M | 10.55M | 11.51M | 11.85M | 922K | 1.04M | 1.15M | 1.25M | 1.36M | 1.04M | 0 | 224.52M | 173.72M | 0 | 29.5M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.65M |
| Capital Lease Obligations | 8.84M | 9.16M | 9.45M | 9.74M | 10.03M | 10.29M | 10.55M | 11.51M | 11.85M | 922K | 1.04M | 1.15M | 1.25M | 1.36M | 1.04M | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 224.52M | 173.72M | 0 | 16.85M |
| Total Liabilities | 20.1M | 20.63M | 21.85M | 22.52M | 22.33M | 28.4M | 25.08M | 33.77M | 38.06M | 20.96M | 17.55M | 17.5M | 36.91M | 19.03M | 18.83M | 12.28M | 236.33M | 181.78M | 0 | 30.9M |
| Total Debt | 10.02M | 10.29M | 10.55M | 10.79M | 11.04M | 11.27M | 11.49M | 12.51M | 12.33M | 1.36M | 1.46M | 1.56M | 1.65M | 1.75M | 1.32M | 0 | 0 | 0 | 0 | 12.65M |
| Net Debt | -21.95M | -22.01M | -17.53M | -16.47M | -50.73M | -29.66M | -130.4M | -39.07M | -44.28M | -50.36M | -62.21M | -63.26M | -261.62M | -43.6M | -40.37M | -70.79M | -68.99M | -102.79M | 0 | 12.4M |
| Debt / Equity | 0.05x | 0.05x | 0.05x | 0.04x | 0.04x | 0.04x | 0.04x | 0.05x | 0.04x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -256.04x | -9.41x |
| Total Equity | 191.36M | 209.38M | 231.63M | 254.04M | 278.77M | 280.8M | 307M | 243.92M | 283.64M | 327.81M | 371.62M | 353.89M | 383.53M | 243.15M | 259.12M | 279.2M | -87.62M | -75.86M | 0 | -30.65M |
| Equity Growth % | -31.35% | -25.43% | -24.55% | 4.15% | -1.72% | -14.34% | -17.39% | -31.07% | -26.05% | 34.82% | 43.41% | 26.75% | 537.72% | 420.51% | - | 1010.81% | - | - | 100% | - |
| Book Value per Share | 2.68 | 2.94 | 3.26 | 3.59 | 3.94 | 3.98 | 4.97 | 4.13 | 4.82 | 5.60 | 6.45 | 6.24 | 7.42 | 4.78 | 5.12 | 5.91 | -1.85 | -1.56 | - | -0.63 |
| Total Shareholders' Equity | 191.36M | 209.38M | 231.63M | 254.04M | 278.77M | 280.8M | 307M | 243.92M | 283.64M | 327.81M | 371.62M | 353.89M | 383.53M | 243.15M | 259.12M | 279.2M | -87.62M | -75.86M | 0 | -30.65M |
| Common Stock | 7K | 7K | 7K | 7K | 7K | 7K | 7K | 6K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 0 | 0 | 0 | 0 |
| Retained Earnings | -631.57M | -608.74M | -581.75M | -554.31M | -524.96M | -489.71M | -457.76M | -419.19M | -372.43M | -318.41M | -265.16M | -226.22M | -191.01M | -160.55M | -140.53M | -117.8M | -100.03M | -87.26M | 0 | -32.5M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 223K | 248K | 154K | 157K | 873K | -248K | -121K | -50K | -507K | -710K | -561K | -1.12M | -1.31M | -1.29M | -958K | -58K | 17K | -12K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |